Shengying Lou
Yiwu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in China.
Journal: Renal failure
Published: November 03, 2025
Antibacterial and anti-biofilm activity of kushenol N against methicillin-resistant Staphylococcus aureus.
Journal: Biochemical and biophysical research communications
Published: September 27, 2025
Dehydroeffusol from Juncus effusus L. exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo.
Journal: International journal of medical microbiology : IJMM
Published: September 16, 2025
Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicans.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 18, 2025
Corrigendum to "Betulonic acid: A review on its sources, biological activities, and molecular mechanisms" [Eur. J. Pharmacol. 998 (2025) 177518].
Journal: European journal of pharmacology
Published: April 03, 2025
Discovery of naphthoquinone-furo-piperidone derivatives as dual targeting agents of STAT3 and NQO1 for the treatment of breast cancer.
Journal: European journal of medicinal chemistry
Published: December 01, 2024
Betulonic acid: A review on its sources, biological activities, and molecular mechanisms.
Journal: European journal of pharmacology
Published: November 19, 2024
Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: September 03, 2024
Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors.
Journal: Current medicinal chemistry
Published: October 29, 2023
Discovery of 2-(1-(3-Chloro-4-cyanophenyl)-1H-pyrazol-3-yl)acetamides as Potent, Selective, and Orally Available Antagonists Targeting the Androgen Receptor.
Journal: Journal of medicinal chemistry
Published: September 26, 2022
Discovery of Novel Indazoles as Potent and Selective PI3Kδ Inhibitors with High Efficacy for Treatment of Hepatocellular Carcinoma.
Journal: Journal of medicinal chemistry
Published: February 22, 2022
Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms.
Journal: Current medicinal chemistry
Published: May 07, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026